ArticleParasite epidemiology and control2026
Prevalence, risk factors, and rifampicin resistance pattern of
Article in Parasite epidemiology and control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) is a significant cause of morbidity and mortality globally, particularly in developing countries. However, in some parts of Ethiopia there is limited information on the prevalence, associated risk factors and the level of drug resistant TB. Therefore, this study aimed to determine TB prevalence, identify associated risk factors, and assess rifampicin resistance in Sekota Town, northwest Ethiopia. Methods: A cross-sectional study was conducted from March to June 2023 at Tefera Hailu Memorial Hospital in Sekota town. Morning sputum and fine needle aspirate samples from pulmonary and extrapulmonary cases, respectively, were collected from 422 individuals who visited the hospital during the study period, and the samples were tested for Results: The overall prevalence of all forms of TB in this study was 19.90 %. Of the overall TB cases, 52.4 % were pulmonary (EPTB), whereas 47.6 % were extra-pulmonary (PTB). Among TB positive cases, the prevalence of rifampicin resistant TB was determined to be 2.4 %. Students (adjusted odds ratio (AOR) = 4.66; 95 % CI: 1.11-19.61), pastoralists (AOR = 2.75; 95 % CI: 1.19-6.33), and merchants (AOR = 13.96; 95 % CI: 1.20-162.40) had higher odds of TB infection. Regular alcohol consumption (AOR = 2.62; 95 % CI: 1.10-6.24) and contact with TB patients (AOR = 3.95; 95 % CI: 2.02-7.33) were associated with increased odds of TB infection. HIV sero-positives and those over the age of 45 years were also found to be more likely to be infected with TB. The prevalence of rifampicin-resistant TB among confirmed cases was 2.4 %. Conclusion: The study revealed a high prevalence of TB, with risk factors including HIV infection, alcohol use, contact with TB patients, and high-risk occupational and social groups such as students, merchants, and pastoralists. Targeted TB prevention and control efforts focusing on these high-risk populations are needed to reduce the disease burden in the study area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.